Natural history of untreated renal cell carcinoma with venous tumor thrombus

被引:146
作者
Reese, Adam C. [1 ]
Whitson, Jared M. [1 ]
Meng, Maxwell V. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[2] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
Carcinoma; Renal cell; Vena cava; Inferior; Survival; VENA-CAVA INVOLVEMENT; PROGNOSTIC-SIGNIFICANCE; SURGICAL-MANAGEMENT; EXTENSION; VEIN; NEPHRECTOMY; EXPERIENCE; SURVIVAL; SURGERY; CANCER;
D O I
10.1016/j.urolonc.2011.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The natural history of untreated renal cell carcinoma (RCC) with venous tumor thrombus (VTT) is poorly characterized. We aimed to describe the natural history of this disease, and to identify prognostic factors associated with disease-specific survival. Materials and methods: We identified patients in the Surveillance, Epidemiology, and End Results (SEER) database with untreated renal cell carcinoma and venous tumor thrombi. Disease-specific median and 1-year survival rates were determined, and disease-free survival curves were plotted using the Kaplan-Meier method. Multivariable Cox regression analyses were performed to identify factors associated with disease-specific and overall survival in this patient group. Results: Of 2,265 patients with RCC and VTT, 390 (17%) underwent no treatment; 278 (71%) patients died during follow-up; of these, 243 deaths (87%) were due to RCC. Median and 1-year disease-specific survival for this group was 5 months and 29%, respectively. On multivariable analysis, the extent of tumor thrombus (HR 1.7 for T3c vs. T3b, 95% CI 1.0-2.7) and the presence of metastases (HR 3.1 for M+ vs. MO, 95% CI 1.7-5.5) were most strongly associated with disease-specific mortality. Conclusions: Prognosis is poor for the majority of untreated patients with RCC and VTT. Supradiaphragmatic thrombi and distant metastases are adverse prognostic factors in this patient group. This information is important when counseling patients as to the risk and benefits of surgical vs. nonoperative management of RCC and VTT. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1305 / 1309
页数:5
相关论文
共 22 条
[1]   Long-term experience with management of renal cell carcinoma involving the inferior vena cava [J].
Bissada, NK ;
Yakout, HH ;
Babanouri, A ;
Elsalamony, T ;
Fahmy, W ;
Gunham, M ;
Hull, GW ;
Chaudhary, UB .
UROLOGY, 2003, 61 (01) :89-92
[2]   The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus [J].
Blute, ML ;
Leibovich, BC ;
Lohse, CM ;
Cheville, JC ;
Zincke, H .
BJU INTERNATIONAL, 2004, 94 (01) :33-41
[3]   Long-term Survival in Patients Undergoing Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Single-Center Experience [J].
Ciancio, Gaetano ;
Manoharan, Murugesan ;
Katkoori, Devendar ;
De Los Santos, Rosely ;
Soloway, Mark S. .
EUROPEAN UROLOGY, 2010, 57 (04) :667-672
[4]   Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma [J].
Ficarra, V ;
Righetti, R ;
D'Amico, A ;
Rubilotta, E ;
Novella, G ;
Malossini, G ;
Mobilio, G .
ONCOLOGY, 2001, 61 (01) :10-15
[5]   Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer [J].
Flanigan, RC ;
Salmon, SE ;
Blumenstein, BA ;
Bearman, SI ;
Roy, V ;
McGrath, PC ;
Caton, JR ;
Munshi, N ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1655-1659
[6]  
FLANIGAN RC, 1987, UROL CLIN N AM, V14, P757
[7]   Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension [J].
Gettman, MT ;
Boelter, CW ;
Cheville, JC ;
Zincke, H ;
Bryant, SC ;
Blute, ML .
JOURNAL OF UROLOGY, 2003, 169 (04) :1282-1286
[8]  
Greene F., 2002, AJCC cancer staging handbook: From the AJCC cancer staging manual, V6th
[9]  
Hotte SJ, 2007, CUAJ-CAN UROL ASSOC, V1, pS34
[10]   Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? [J].
Kim, HL ;
Zisman, A ;
Han, KR ;
Figlin, RA ;
Belldegrun, AS .
JOURNAL OF UROLOGY, 2004, 171 (02) :588-591